I don't know the exact capacity. I've been part of discussions with an effort to mobilize capacity for tracking the variants. It's multi-faceted related to sequencing capacity, and also linking this to follow-up of the implications of the variant in its impact on transmission, as well as the disease profile of people who have those variants. I'm not in a position to comment on the scale of that capacity at this point, other than to say I've been part of conversations where plans are under way to scale it up.
On February 1st, 2021. See this statement in context.